Sadhana Nitrochem Limited

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has informed the Exchange about the resignation of a Director/KMP/SMP, but no further details are provided.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and listing on stock exchanges.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has informed the Exchange regarding the resignation of Mr. Vimal Rameshchandra Jain as Chief Financial Officer (CFO) of the company, effective October 13, 2026.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on September 30, 2026, and informed the Exchange regarding voting results.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited held its 53rd Annual General Meeting on September 30, 2026, through video conferencing, in compliance with regulatory requirements. The meeting was attended by the requisite quorum, and the company's directors and auditors were introduced. The meeting approved various resolutions, including the adoption of financial statements, appointment of directors, and reappointment of the executive chairman and managing director.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has received trading approval for 6,75,00,000 equity shares issued under a preferential issue, which will be listed on the NSE from September 25, 2026.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has informed the Exchange about a copy of newspaper publication regarding the notice of the 53rd Annual General Meeting and e-voting.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has published unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, as approved by the Board of Directors on August 7, 2026.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, confirming no deviation or variation in the use of proceeds raised through the Rights Issue.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, stating that there is no deviation from the objects of the Rights Issue. The report was considered by the Audit Committee and will be available on the company's website.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, and approved the allotment of 6.75 crore equity shares on a preferential basis to eligible shareholders.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has received in-principle approval from BSE and NSE for a proposed preferential issue of 6,75,00,000 equity shares.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on June 30, 2026.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in the securities of the Company for Designated Persons and their immediate relative shall be closed from Wednesday, 1st July, 2026 till the expiry of 48 hours after the declaration of Unaudited Financial Results of the Company to the Stock Exchanges for the quarter ended on June 30, 2026.

Sadhana Nitrochem Limited

Sadhana Nitrochem Limited responded to a clarification request from the National Stock Exchange regarding its financial results for the quarter ended June 30, 2025, addressing discrepancies in XBRL filing and providing a legible copy of the financial results. The company also announced the resignation of its CFO, appointment of new executives, and monetization of its investment in a subsidiary.